Intranasal agomelatine solid lipid nanoparticles to enhance brain delivery: formulation optimization and in vivo pharmacokinetics

摘要

PurposeAgomelatine is a novel antidepressant drug suffering from an extensive first-pass metabolism leading to a diminished absolute bioavailability. The aim of the study is: first to enhance its absolute bioavailability, and second to increase its brain delivery.